Esketamine induces embryonic and cardiac malformation through regulating the nkx2.5 and gata4 in zebrafish
Abstract Esketamine (EK) has been widely used in the treatment of depression, but the effects of EK prenatal treatment on embryonic heart development have been rarely reported. This study assesses the effects of varying concentrations of EK on embryonic development and cardiogenesis to determine the...
Auteurs principaux: | Shuang Li, Xiang Li, Rui Zhao, Tingyu Jiang, Qiuyun Ou, Huansen Huang, Jiancheng Tang |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Nature Portfolio
2025-02-01
|
Collection: | Scientific Reports |
Accès en ligne: | https://doi.org/10.1038/s41598-025-91315-2 |
Documents similaires
-
Nkx2.7 and Nkx2.5 function redundantly and are required for cardiac morphogenesis of zebrafish embryos.
par: Chi-Tang Tu, et autres
Publié: (2009-01-01) -
Activation of the Nkx2.5–Calr–p53 signaling pathway by hyperglycemia induces cardiac remodeling and dysfunction in adult zebrafish
par: Yanyi Sun, et autres
Publié: (2017-10-01) -
Art27 interacts with GATA4, FOG2 and NKX2.5 and is a novel co-repressor of cardiac genes.
par: Daniel R Carter, et autres
Publié: (2014-01-01) -
GATA factors lie upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects cardiogenesis.
par: Brewer, A, et autres
Publié: (2005) -
The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs.
par: Jenny Schlesinger, et autres
Publié: (2011-02-01)